Follow the people · Insider
Ilan Daskal
Ilan Daskal files insider transactions with the SEC as an evp, cfo of Viavi Solutions (VIAV). We hold 1 disclosed purchase or sale filed since 12 November 2008, 1 of them in the last 90 days.
- Files forVIAV
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure31 August 2026
Positions held
9 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 28 November 2023 — 31 August 2026EVP, CFO · Viavi Solutions (VIAV)56 Form 4 lines · source: SEC Form 4
- Filed 8 April 2021 — 2 September 2023EVP, Chief Financial Officer · Bio-Rad Laboratories (BIO BIOB)41 Form 4 lines · source: SEC Form 4
- Filed 18 March 2020 — 21 July 2022Director · Natus Medical (NTUS)6 Form 4 lines · source: SEC Form 4
- Filed 8 April 2020 — 2 September 2020EVP, Chief Financial Officer · Bio-Rad Laboratories (BIO,BIOB)5 Form 4 lines · source: SEC Form 4
- Filed 8 April 2019 — 8 April 2019EVP, CFO · Bio-Rad Laboratories (BIO, BIOB)2 Form 4 lines · source: SEC Form 4
- Filed 7 August 2015 — 18 April 2017Director · Ixia (XXIA)7 Form 4 lines · source: SEC Form 4
- Filed 8 April 2016 — 8 April 2016EVP & CFO Designee · Sunedison (SUNE)1 Form 4 line · source: SEC Form 4
- Filed 9 April 2015 — 9 April 2015EVP, Chief Financial Officer · Cepheid (CPHD)2 Form 4 lines · source: SEC Form 4
- Filed 11 November 2008 — 13 January 2015Executive Vice President & CFO · International Rectifier Corp /de/ (IRF)182 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 55,114 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- had shares withheld for tax on 24,857 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- exercised options over 47,420 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- had shares withheld for tax on 21,387 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- exercised options over 55,114 shares of Viavi Solutions (a derivative holding)SEC Form 431 August 2026Restricted Stock Unit · traded 28 August 2026 · filed 31 August 2026
- exercised options over 47,420 shares of Viavi Solutions (a derivative holding)SEC Form 431 August 2026Restricted Stock Unit · traded 28 August 2026 · filed 31 August 2026
- was granted 34,861 shares of Viavi Solutions (a derivative holding)SEC Form 431 August 2026Restricted Stock Units · traded 28 August 2026 · filed 31 August 2026
- was granted 34,861 shares of Viavi Solutions (a derivative holding)SEC Form 431 August 2026Market Stock Units · traded 28 August 2026 · filed 31 August 2026
- ▼ sold on the open market 30,257 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 31 August 2026 · filed 31 August 2026
- ▼ sold on the open market 26,033 shares of Viavi SolutionsSEC Form 431 August 2026Common Stock · traded 31 August 2026 · filed 31 August 2026
- ▼ sold on the open market 25,100 shares of Viavi SolutionsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 39,709 shares of Viavi SolutionsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 105,191 shares of Viavi SolutionsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- exercised options over 62,645 shares of Viavi Solutions (a derivative holding)SEC Form 41 December 2025Market Stock Units · traded 28 November 2025 · filed 1 December 2025
- exercised options over 35,984 shares of Viavi Solutions (a derivative holding)SEC Form 41 December 2025Market Stock Units · traded 28 November 2025 · filed 1 December 2025
- exercised options over 65,944 shares of Viavi Solutions (a derivative holding)SEC Form 41 December 2025Restricted Stock Unit · traded 28 November 2025 · filed 1 December 2025
- exercised options over 37,879 shares of Viavi Solutions (a derivative holding)SEC Form 41 December 2025Restricted Stock Unit · traded 28 November 2025 · filed 1 December 2025
- exercised options over 62,645 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- had shares withheld for tax on 28,253 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- exercised options over 35,984 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- had shares withheld for tax on 16,229 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- exercised options over 65,944 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- had shares withheld for tax on 29,741 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- exercised options over 37,879 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- had shares withheld for tax on 17,084 shares of Viavi SolutionsSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- exercised options over 70,545 shares of Viavi Solutions (a derivative holding)SEC Form 425 September 2025Market Stock Units · traded 23 September 2025 · filed 25 September 2025
- was granted 35,984 shares of Viavi Solutions (a derivative holding)SEC Form 425 September 2025Market Stock Units · traded 23 September 2025 · filed 25 September 2025
- was granted 62,645 shares of Viavi Solutions (a derivative holding)SEC Form 425 September 2025Market Stock Units · traded 23 September 2025 · filed 25 September 2025
- exercised options over 70,545 shares of Viavi SolutionsSEC Form 425 September 2025Common Stock · traded 23 September 2025 · filed 25 September 2025
- had shares withheld for tax on 31,816 shares of Viavi SolutionsSEC Form 425 September 2025Common Stock · traded 23 September 2025 · filed 25 September 2025
- exercised options over 55,115 shares of Viavi Solutions (a derivative holding)SEC Form 42 September 2025Restricted Stock Unit · traded 28 August 2025 · filed 2 September 2025
- was granted 142,258 shares of Viavi Solutions (a derivative holding)SEC Form 42 September 2025Restricted Stock Unit · traded 28 August 2025 · filed 2 September 2025
- was granted 142,258 shares of Viavi Solutions (a derivative holding)SEC Form 42 September 2025Market Stock Units · traded 28 August 2025 · filed 2 September 2025
- exercised options over 55,115 shares of Viavi SolutionsSEC Form 42 September 2025Common Stock · traded 28 August 2025 · filed 2 September 2025
- had shares withheld for tax on 24,857 shares of Viavi SolutionsSEC Form 42 September 2025Common Stock · traded 28 August 2025 · filed 2 September 2025
- ▼ sold on the open market 82,095 shares of Viavi SolutionsSEC Form 46 June 2025Common Stock · traded 4 June 2025 · filed 6 June 2025
- exercised options over 39,783 shares of Viavi Solutions (a derivative holding)SEC Form 42 December 2024Market Stock Units · traded 28 November 2024 · filed 2 December 2024
- exercised options over 22,851 shares of Viavi Solutions (a derivative holding)SEC Form 42 December 2024Market Stock Units · traded 28 November 2024 · filed 2 December 2024
- exercised options over 65,944 shares of Viavi Solutions (a derivative holding)SEC Form 42 December 2024Restricted Stock Unit · traded 28 November 2024 · filed 2 December 2024
- exercised options over 37,879 shares of Viavi Solutions (a derivative holding)SEC Form 42 December 2024Restricted Stock Unit · traded 28 November 2024 · filed 2 December 2024
- exercised options over 39,783 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- had shares withheld for tax on 20,162 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- exercised options over 22,851 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- had shares withheld for tax on 11,581 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- exercised options over 65,944 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- had shares withheld for tax on 33,421 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- exercised options over 37,879 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- had shares withheld for tax on 19,198 shares of Viavi SolutionsSEC Form 42 December 2024Common Stock · traded 28 November 2024 · filed 2 December 2024
- was granted 39,783 shares of Viavi Solutions (a derivative holding)SEC Form 426 September 2024Market Stock Units · traded 24 September 2024 · filed 26 September 2024
- was granted 22,851 shares of Viavi Solutions (a derivative holding)SEC Form 426 September 2024Market Stock Units · traded 24 September 2024 · filed 26 September 2024
- was granted 165,343 shares of Viavi Solutions (a derivative holding)SEC Form 430 August 2024Market Stock Units · traded 28 August 2024 · filed 30 August 2024
- was granted 165,343 shares of Viavi Solutions (a derivative holding)SEC Form 430 August 2024Restricted Stock Unit · traded 28 August 2024 · filed 30 August 2024
- was granted 113,636 shares of Viavi Solutions (a derivative holding)SEC Form 430 November 2023Market Stock Units · traded 28 November 2023 · filed 30 November 2023
- was granted 263,774 shares of Viavi Solutions (a derivative holding)SEC Form 430 November 2023Market Stock Units · traded 28 November 2023 · filed 30 November 2023
- was granted 113,636 shares of Viavi Solutions (a derivative holding)SEC Form 430 November 2023Restricted Stock Unit · traded 28 November 2023 · filed 30 November 2023
- was granted 263,774 shares of Viavi Solutions (a derivative holding)SEC Form 430 November 2023Restricted Stock Unit · traded 28 November 2023 · filed 30 November 2023
- was granted 4,007 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2023Restricted Stock Units · traded 1 September 2023 · filed 6 September 2023
- exercised options over 694 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2023Restricted Stock Units · traded 1 September 2023 · filed 6 September 2023
- exercised options over 456 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2023Restricted Stock Units · traded 1 September 2023 · filed 6 September 2023
- exercised options over 542 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2023Restricted Stock Units · traded 2 September 2023 · filed 6 September 2023
- exercised options over 694 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 1 September 2023 · filed 6 September 2023
- had shares withheld for tax on 240 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 1 September 2023 · filed 6 September 2023
- exercised options over 456 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 1 September 2023 · filed 6 September 2023
- had shares withheld for tax on 209 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 1 September 2023 · filed 6 September 2023
- exercised options over 542 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 2 September 2023 · filed 6 September 2023
- had shares withheld for tax on 269 shares of Bio-Rad LaboratoriesSEC Form 46 September 2023Bio-Rad A Common Stock · traded 2 September 2023 · filed 6 September 2023
- exercised options over 700 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 411 April 2023Restricted Stock Units · traded 8 April 2023 · filed 11 April 2023
- exercised options over 700 shares of Bio-Rad LaboratoriesSEC Form 411 April 2023Bio-Rad A Common Stock · traded 8 April 2023 · filed 11 April 2023
- had shares withheld for tax on 243 shares of Bio-Rad LaboratoriesSEC Form 411 April 2023Bio-Rad A Common Stock · traded 8 April 2023 · filed 11 April 2023
- exercised options over 541 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 47 September 2022Restricted Stock Units · traded 2 September 2022 · filed 7 September 2022
- exercised options over 541 shares of Bio-Rad LaboratoriesSEC Form 47 September 2022Bio-Rad A Common Stock · traded 2 September 2022 · filed 7 September 2022
- had shares withheld for tax on 269 shares of Bio-Rad LaboratoriesSEC Form 47 September 2022Bio-Rad A Common Stock · traded 2 September 2022 · filed 7 September 2022
- was granted 2,776 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2022Restricted Stock Units · traded 1 September 2022 · filed 6 September 2022
- exercised options over 455 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 46 September 2022Restricted Stock Units · traded 1 September 2022 · filed 6 September 2022
- exercised options over 455 shares of Bio-Rad LaboratoriesSEC Form 46 September 2022Bio-Rad A Common Stock · traded 1 September 2022 · filed 6 September 2022
- had shares withheld for tax on 226 shares of Bio-Rad LaboratoriesSEC Form 46 September 2022Bio-Rad A Common Stock · traded 1 September 2022 · filed 6 September 2022
- returned to the issuer 18,937 shares of Natus MedicalSEC Form 421 July 2022Common Stock, $0.001 par value per share · traded 21 July 2022 · filed 21 July 2022
- was granted 5,075 shares of Natus MedicalSEC Form 417 June 2022Common Stock, $0.001 par value per share · traded 15 June 2022 · filed 17 June 2022
- exercised options over 700 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 411 April 2022Restricted Stock Units · traded 8 April 2022 · filed 11 April 2022
- exercised options over 700 shares of Bio-Rad LaboratoriesSEC Form 411 April 2022Bio-Rad A Common Stock · traded 8 April 2022 · filed 11 April 2022
- had shares withheld for tax on 257 shares of Bio-Rad LaboratoriesSEC Form 411 April 2022Bio-Rad A Common Stock · traded 8 April 2022 · filed 11 April 2022
- ▼ sold on the open market 270 shares of Bio-Rad LaboratoriesSEC Form 48 September 2021Bio-Rad A Common Stock · traded 3 September 2021 · filed 8 September 2021
- was granted 1,823 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 43 September 2021Restricted Stock Units · traded 1 September 2021 · filed 3 September 2021
- was granted 1,823 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 43 September 2021Non-Qualified Stock Option (right to buy) · traded 1 September 2021 · filed 3 September 2021
- exercised options over 540 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 43 September 2021Non-Qualified Stock Option (right to buy) · traded 2 September 2021 · filed 3 September 2021
- exercised options over 541 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 43 September 2021Restricted Stock Units · traded 2 September 2021 · filed 3 September 2021
- exercised options over 540 shares of Bio-Rad LaboratoriesSEC Form 43 September 2021Bio-Rad A Common Stock · traded 2 September 2021 · filed 3 September 2021
- ▼ sold on the open market 440 shares of Bio-Rad LaboratoriesSEC Form 43 September 2021Bio-Rad A Common Stock · traded 2 September 2021 · filed 3 September 2021
- ▼ sold on the open market 100 shares of Bio-Rad LaboratoriesSEC Form 43 September 2021Bio-Rad A Common Stock · traded 2 September 2021 · filed 3 September 2021
- exercised options over 541 shares of Bio-Rad LaboratoriesSEC Form 43 September 2021Bio-Rad A Common Stock · traded 2 September 2021 · filed 3 September 2021
- had shares withheld for tax on 269 shares of Bio-Rad LaboratoriesSEC Form 43 September 2021Bio-Rad A Common Stock · traded 2 September 2021 · filed 3 September 2021
- exercised options over 1,400 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 45 August 2021Non-Qualified Stock Option (right to buy) · traded 4 August 2021 · filed 5 August 2021
- exercised options over 1,400 shares of Bio-Rad LaboratoriesSEC Form 45 August 2021Bio-Rad A Common Stock · traded 4 August 2021 · filed 5 August 2021
- ▼ sold on the open market 857 shares of Bio-Rad LaboratoriesSEC Form 45 August 2021Bio-Rad A Common Stock · traded 4 August 2021 · filed 5 August 2021
- ▼ sold on the open market 954 shares of Bio-Rad LaboratoriesSEC Form 45 August 2021Bio-Rad A Common Stock · traded 4 August 2021 · filed 5 August 2021
- ▼ sold on the open market 489 shares of Bio-Rad LaboratoriesSEC Form 45 August 2021Bio-Rad A Common Stock · traded 4 August 2021 · filed 5 August 2021
- was granted 5,214 shares of Natus MedicalSEC Form 421 June 2021Common Stock, $0.001 par value per share · traded 17 June 2021 · filed 21 June 2021
- ▼ sold on the open market 2,500 shares of Natus MedicalSEC Form 415 June 2021Common Stock, $0.001 par vale per share · traded 11 June 2021 · filed 15 June 2021
- exercised options over 700 shares of Bio-Rad LaboratoriesSEC Form 49 April 2021Bio-Rad A Common Stock · traded 8 April 2021 · filed 9 April 2021
- had shares withheld for tax on 250 shares of Bio-Rad LaboratoriesSEC Form 49 April 2021Bio-Rad A Common Stock · traded 8 April 2021 · filed 9 April 2021
- exercised options over 700 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 49 April 2021Restricted Stock Units · traded 8 April 2021 · filed 9 April 2021
- was granted 2,166 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 44 September 2020Restricted Stock Units · traded 2 September 2020 · filed 4 September 2020
- was granted 2,166 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 44 September 2020Non-Qualified Stock Option (right to buy) · traded 2 September 2020 · filed 4 September 2020
- was granted 3,560 shares of Natus MedicalSEC Form 422 June 2020Common Stock, $0.001 par vale per share · traded 19 June 2020 · filed 22 June 2020
- exercised options over 700 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 49 April 2020Restricted Stock Units · traded 8 April 2020 · filed 9 April 2020
- exercised options over 700 shares of Bio-Rad LaboratoriesSEC Form 49 April 2020Bio-Rad A Common Stock · traded 8 April 2020 · filed 9 April 2020
- had shares withheld for tax on 243 shares of Bio-Rad LaboratoriesSEC Form 49 April 2020Bio-Rad A Common Stock · traded 8 April 2020 · filed 9 April 2020
- was granted 7,588 shares of Natus MedicalSEC Form 420 March 2020Common Stock, $0.001 par vale per share · traded 18 March 2020 · filed 20 March 2020
- was granted 3,500 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 49 April 2019Restricted Stock Units · traded 8 April 2019 · filed 9 April 2019
- was granted 3,500 shares of Bio-Rad Laboratories (a derivative holding)SEC Form 49 April 2019Non-Qualified Stock Option (right to buy) · traded 8 April 2019 · filed 9 April 2019
- returned to the issuer 16,140 shares of IxiaSEC Form 420 April 2017Common Stock · traded 18 April 2017 · filed 20 April 2017
- returned to the issuer 15,000 shares of Ixia (a derivative holding)SEC Form 420 April 2017Employee Stock Option (Right to Buy) · traded 18 April 2017 · filed 20 April 2017
- returned to the issuer 15,000 shares of Ixia (a derivative holding)SEC Form 420 April 2017Employee Stock Option (Right to Buy) · traded 18 April 2017 · filed 20 April 2017
- was granted 9,709 shares of IxiaSEC Form 47 June 2016Common Stock · traded 3 June 2016 · filed 7 June 2016
- was granted 15,000 shares of Ixia (a derivative holding)SEC Form 47 June 2016Stock Option (right to buy) · traded 3 June 2016 · filed 7 June 2016
- was granted 400,000 shares of SunedisonSEC Form 411 April 2016Restricted Stock Units · traded 8 April 2016 · filed 11 April 2016
- was granted 6,431 shares of IxiaSEC Form 411 August 2015Common Stock · traded 7 August 2015 · filed 11 August 2015
- was granted 15,000 shares of Ixia (a derivative holding)SEC Form 411 August 2015Stock Option (right to buy) · traded 7 August 2015 · filed 11 August 2015
- was granted 10,000 shares of CepheidSEC Form 413 April 2015Common Stock · traded 9 April 2015 · filed 13 April 2015
- was granted 100,000 shares of Cepheid (a derivative holding)SEC Form 413 April 2015Non-qualified Stock Option (Right to Buy) · traded 9 April 2015 · filed 13 April 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.